CD95 Structure, Aggregation and Cell Signaling
Nicolas Levoin, Mickaël Jean, Patrick Legembre · Frontiers in Cell and Developmental Biology · 2020
CD95 is a pre-ligand-associated transmembrane (TM) receptor. The interaction with its ligand CD95L brings to a next level its aggregation and triggers different signaling pathways, leading to cell motility, differentiation or cell death. This diversity of biological responses associated with a unique receptor devoid of enzymatic property raises the question of whether different ligands exist, or whether the fine-tuned control of CD95 aggregation and conformation, its distribution within certain plasma membrane sub-domains or the pattern of post-translational modifications account for this such broad-range of cell signaling. Herein, we review how the different domains of CD95 and their post-translational modifications or the different forms of CD95L can participate in the receptor aggregation and induction of cell signaling. Understanding how CD95 response goes from cell death to cell proliferation, differentiation and motility is a prerequisite to reveal novel therapeutic options to treat chronic inflammatory disorders and cancers.
Cited by 45 works. doi:10.3389/fcell.2020.00314 Open-access PDF
Authors
References
- MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
- The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
- Death Receptors: Signaling and Modulation
- Inference of Macromolecular Assemblies from Crystalline State
- Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.
- FAP-1: A Protein Tyrosine Phosphatase That Associates with Fas
- Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes
- The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor
- Fas transduces activation signals in normal human T lymphocytes.
- NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain